FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010079762> ?p ?o ?g. }

• W2010079762 endingPage "307" @default.
• W2010079762 startingPage "303" @default.
• W2010079762 abstract "Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS). Increased plasma levels of ADMA may indicate endothelial dysfunction and increased risk of angiopathy. The relation of ADMA to diabetes, glycemic control, and renal function, especially early diabetic hyperfiltration, remains unknown. We tried to evaluate whether there is an association between ADMA and glycosylated hemoglobin (GHbA1c) on the one hand and glomerular filtration rate (GFR) on the other hand in diabetic subjects with normal or slightly increased GFR. We also studied whether plasma ADMA is associated with some risk factors of vasculopathy (hypercholesterolemia and hypertension). The study subjects consisted of 86 patients with type 2 diabetes and 65 control subjects. Plasma ADMA levels were measured by high-pressure liquid chromatography as o-pthalaldehyde (OPA) derivatives and GFR was determined by the plasma clearance of chromium 51–EDTA. The diabetic patients had lower plasma ADMA levels than the nondiabetic control subjects (0.29 ± 0.15 v 0.34 ± 0.16 μmol/L, P <.03). In the diabetic subjects, plasma ADMA concentrations were inversely correlated with GHbA1c (R = −0.28, P =.01). In a multivariate linear model, significant predictors of ADMA were GFR (R = −0.32, P =.008) in diabetic subjects and GHbA1c (R = −0.19, P =.03) and GFR (R = −0.19, P =.02) in all subjects. Plasma ADMA was not associated with risk factors of vasculopathy. We conclude that diabetic patients with a normal or slightly increased GFR have lower circulating ADMA concentrations than nondiabetic control subjects. In type 2 diabetic patients high GFR and poor glycemic control were related to low plasma ADMA concentrations. Copyright 2003, Elsevier Science (USA). All rights reserved." @default.
• W2010079762 created "2016-06-24" @default.
• W2010079762 creator A5005794053 @default.
• W2010079762 creator A5008801742 @default.
• W2010079762 creator A5036103548 @default.
• W2010079762 creator A5062278583 @default.
• W2010079762 creator A5065894689 @default.
• W2010079762 creator A5070875834 @default.
• W2010079762 creator A5080389661 @default.
• W2010079762 creator A5081986241 @default.
• W2010079762 date "2003-03-01" @default.
• W2010079762 modified "2023-10-01" @default.
• W2010079762 title "Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy" @default.
• W2010079762 cites W1970798352 @default.
• W2010079762 cites W1975861856 @default.
• W2010079762 cites W1998347753 @default.
• W2010079762 cites W2000881220 @default.
• W2010079762 cites W2007880055 @default.
• W2010079762 cites W2008406265 @default.
• W2010079762 cites W2016833774 @default.
• W2010079762 cites W2023492147 @default.
• W2010079762 cites W2026817711 @default.
• W2010079762 cites W2028574541 @default.
• W2010079762 cites W2032167313 @default.
• W2010079762 cites W2041493084 @default.
• W2010079762 cites W2058385357 @default.
• W2010079762 cites W2060117705 @default.
• W2010079762 cites W2067805552 @default.
• W2010079762 cites W2073823341 @default.
• W2010079762 cites W2080105057 @default.
• W2010079762 cites W2086773850 @default.
• W2010079762 cites W2091283262 @default.
• W2010079762 cites W2100500261 @default.
• W2010079762 cites W2103636227 @default.
• W2010079762 cites W2106478344 @default.
• W2010079762 cites W2108702111 @default.
• W2010079762 cites W2124279221 @default.
• W2010079762 cites W2145027776 @default.
• W2010079762 cites W2161769916 @default.
• W2010079762 cites W2166969544 @default.
• W2010079762 cites W2169182236 @default.
• W2010079762 cites W2316926768 @default.
• W2010079762 cites W2331274940 @default.
• W2010079762 cites W2411809327 @default.
• W2010079762 cites W4299493480 @default.
• W2010079762 doi "https://doi.org/10.1053/meta.2003.50048" @default.
• W2010079762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12647267" @default.
• W2010079762 hasPublicationYear "2003" @default.
• W2010079762 type Work @default.
• W2010079762 sameAs 2010079762 @default.
• W2010079762 citedByCount "80" @default.
• W2010079762 countsByYear W20100797622012 @default.
• W2010079762 countsByYear W20100797622013 @default.
• W2010079762 countsByYear W20100797622014 @default.
• W2010079762 countsByYear W20100797622015 @default.
• W2010079762 countsByYear W20100797622016 @default.
• W2010079762 countsByYear W20100797622017 @default.
• W2010079762 countsByYear W20100797622018 @default.
• W2010079762 countsByYear W20100797622019 @default.
• W2010079762 countsByYear W20100797622021 @default.
• W2010079762 countsByYear W20100797622022 @default.
• W2010079762 crossrefType "journal-article" @default.
• W2010079762 hasAuthorship W2010079762A5005794053 @default.
• W2010079762 hasAuthorship W2010079762A5008801742 @default.
• W2010079762 hasAuthorship W2010079762A5036103548 @default.
• W2010079762 hasAuthorship W2010079762A5062278583 @default.
• W2010079762 hasAuthorship W2010079762A5065894689 @default.
• W2010079762 hasAuthorship W2010079762A5070875834 @default.
• W2010079762 hasAuthorship W2010079762A5080389661 @default.
• W2010079762 hasAuthorship W2010079762A5081986241 @default.
• W2010079762 hasConcept C126322002 @default.
• W2010079762 hasConcept C134018914 @default.
• W2010079762 hasConcept C159641895 @default.
• W2010079762 hasConcept C185592680 @default.
• W2010079762 hasConcept C2777180221 @default.
• W2010079762 hasConcept C2777468819 @default.
• W2010079762 hasConcept C2779877776 @default.
• W2010079762 hasConcept C2780473172 @default.
• W2010079762 hasConcept C2780972559 @default.
• W2010079762 hasConcept C515207424 @default.
• W2010079762 hasConcept C55493867 @default.
• W2010079762 hasConcept C555293320 @default.
• W2010079762 hasConcept C71924100 @default.
• W2010079762 hasConceptScore W2010079762C126322002 @default.
• W2010079762 hasConceptScore W2010079762C134018914 @default.
• W2010079762 hasConceptScore W2010079762C159641895 @default.
• W2010079762 hasConceptScore W2010079762C185592680 @default.
• W2010079762 hasConceptScore W2010079762C2777180221 @default.
• W2010079762 hasConceptScore W2010079762C2777468819 @default.
• W2010079762 hasConceptScore W2010079762C2779877776 @default.
• W2010079762 hasConceptScore W2010079762C2780473172 @default.
• W2010079762 hasConceptScore W2010079762C2780972559 @default.
• W2010079762 hasConceptScore W2010079762C515207424 @default.
• W2010079762 hasConceptScore W2010079762C55493867 @default.
• W2010079762 hasConceptScore W2010079762C555293320 @default.
• W2010079762 hasConceptScore W2010079762C71924100 @default.
• W2010079762 hasIssue "3" @default.
• W2010079762 hasLocation W20100797621 @default.

• next